Cortera earned FDA clearance in August and was introduced in a limited release, according to a news release. It is a posterior fixation platform designed based on feedback from spine surgeons. Cortera has modules for open and minimally invasive spine surgery.
Surgalign plans to further develop the Cortera, including integration with the Holo Portal guidance system. Cortera is Surgalisgn’s first organically developed product.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.